Overview

Based on accelerated computing and advanced algorithms, artificial intelligence (AI) has become a game-changer in diverse fields. In biomedical science, AI models based on machine learning, deep learning, and generative AI, together with upgraded computational and systems biology, provide smart, precise, and personalized medicine and healthcare. In the field of clinical immunology, which deals with intrinsic complicated immune systems for combating immunological disorders, AI technologies have the potential to solve problems based on identification, prediction, simulation, and modeling. AI algorithms may impact sustainable clinical healthcare and future immunology diagnoses. AI-Assisted Computational Approaches for Immunological Disorders explores precision clinical medicine and personalized healthcare in major immunological disorders, such as immunodeficiency, autoimmune diseases, allergies, asthma, cancers, and neurological diseases. It analyzes clinical healthcare big data, genomics, and high-throughput multiple omics based on single-cell and high-dimensional data for their technical advances, clinical applications, challenges, and future directions. Covering topics such as cell therapy, reducing complications, and drug development, this book is an excellent resource for immunologists, biologists, healthcare practitioners, professionals, researchers, scholars, academicians, and more.

Full Product Details

9798369397268

Table of Contents

Reviews

Author Information

Dr. Jen-Tsung Chen is a professor of cell biology at the National University of Kaohsiung in Taiwan. He teaches cell biology, genomics, proteomics, plant physiology, and plant biotechnology. Dr. Chen’s research interests include bioactive compounds, chromatography techniques, plant molecular biology, plant biotechnology, bioinformatics, and systems pharmacology. He is an active editor of academic books and international journals to advance the exploration of multidisciplinary knowledge involving plant physiology, plant biotechnology, nanotechnology, materials science, ethnopharmacology, and systems biology. He serves as an associate editor, editorial board member, and guest editor in reputed journals. Dr. Chen published books in collaboration with international publishers, and he is handling book projects on diverse topics such as AI technologies, drug discovery, drug development, herbal medicine, medicinal biotechnology, nanotechnology, bioengineering, plant functional genomics, plant speed breeding, epigenetics, functional RNAs, and CRISPR-based genome editing. Dr. Chen is a productive author in academic publications and was recognized as one of the World's Top 2% Scientists 2023, 2024, and 2025 by Elsevier and Stanford University. Dr. Chen received the Springer Nature Editor of Distinction Award in 2025.

Tab Content 6

Countries Available